Your browser doesn't support javascript.
loading
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers.
Merrick, Sophie; Nankivell, Matthew; Quartagno, Matteo; Clarke, Caroline S; Joharatnam-Hogan, Nalinie; Waddell, Tom; O'Carrigan, Brent; Seckl, Michael; Ghorani, Ehsan; Banks, Emma; Edmonds, Kim; Bray, George; Woodward, Rose; Bennett, Rachel; Badrock, Jonathan; Hudson, Will; Langley, Ruth E; Vasudev, Naveen; Pickering, Lisa; Gilbert, Duncan C.
Afiliación
  • Merrick S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Nankivell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Quartagno M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Clarke CS; University College London (UCL) Research Department of Primary Care and Population Health, Upper 3rd Floor, UCL Medical School, Royal Free Campus, London NW3 2PF, UK.
  • Joharatnam-Hogan N; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Waddell T; The Christie NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK.
  • O'Carrigan B; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge Biomedical Campus Hill's Road, Cambridge CB2 0QQ, UK.
  • Seckl M; Imperial College London, Division of Cancer, 2nd floor U201 Hammersmith Hospital Campus, London W12 0NN, UK.
  • Ghorani E; Imperial College London, Division of Cancer, 2nd floor U201 Hammersmith Hospital Campus, London W12 0NN, UK.
  • Banks E; Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds LS9 7TF, UK.
  • Edmonds K; Royal Marsden Hospital, 203 Fulham Rd, Chelsea, London SW3 6JJ, UK.
  • Bray G; University College London (UCL) Research Department of Primary Care and Population Health, Upper 3rd Floor, UCL Medical School, Royal Free Campus, London NW3 2PF, UK.
  • Woodward R; Action Kidney Cancer, 11th Floor, 3 Piccadilly Place, Manchester M1 3BN, UK.
  • Bennett R; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Badrock J; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Hudson W; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Langley RE; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK.
  • Vasudev N; Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds LS9 7TF, UK.
  • Pickering L; Royal Marsden Hospital, 203 Fulham Rd, Chelsea, London SW3 6JJ, UK.
  • Gilbert DC; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, 2nd Floor 90 High Holborn, London WC1V 6LJ, UK. Electronic address: duncan.gilbert@ucl.ac.uk.
Contemp Clin Trials ; 124: 107030, 2023 01.
Article en En | MEDLINE | ID: mdl-36519749
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2023 Tipo del documento: Article